Calsona, Mia Monique A.
HRN: 28-42-96 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/25/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/25/2026
02/26/2026
IV
900mg
3 Doses
Nonhealing Perineal Wound, S/p Episiorrhaphy
Checking Initial Appropriateness
02/26/2026
METRONIDAZOLE 500MG (TAB)
02/26/2026
03/04/2026
PO
500 Mg
TID
Thickly MSAF
Checking Initial Appropriateness
02/26/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/26/2026
03/02/2026
IV
500 Mg
Q6
Wound Dehiscence Sp Episiorhaphy
Checking Initial Appropriateness
02/27/2026
CLINDAMYCIN 300MG (CAP)
02/27/2026
03/05/2026
ORAL
300mg
TID X 7days
Wound Dihescence
Checking Initial Appropriateness
02/27/2026
CEFTRIAXONE 1G (VIAL)
02/27/2026
03/06/2026
IV
2 G
OD
Wound Dehiscence; S/P NSVD
Checking Initial Appropriateness